BioLife Solutions Debt to Equity Ratio 2012-2025 | BLFS
Current and historical debt to equity ratio values for BioLife Solutions (BLFS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. BioLife Solutions debt/equity for the three months ending December 31, 2025 was 0.00.
| BioLife Solutions Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-12-31 | $0.03B | $0.37B | 0.09 |
| 2025-09-30 | $0.04B | $0.35B | 0.11 |
| 2025-06-30 | $0.04B | $0.35B | 0.12 |
| 2025-03-31 | $0.04B | $0.35B | 0.12 |
| 2024-12-31 | $0.05B | $0.35B | 0.15 |
| 2024-09-30 | $0.06B | $0.33B | 0.17 |
| 2024-06-30 | $0.05B | $0.32B | 0.17 |
| 2024-03-31 | $0.07B | $0.33B | 0.21 |
| 2023-12-31 | $0.08B | $0.34B | 0.22 |
| 2023-09-30 | $0.08B | $0.33B | 0.24 |
| 2023-06-30 | $0.08B | $0.35B | 0.23 |
| 2023-03-31 | $0.09B | $0.36B | 0.25 |
| 2022-12-31 | $0.09B | $0.36B | 0.24 |
| 2022-09-30 | $0.08B | $0.41B | 0.20 |
| 2022-06-30 | $0.06B | $0.41B | 0.14 |
| 2022-03-31 | $0.07B | $0.48B | 0.14 |
| 2021-12-31 | $0.08B | $0.48B | 0.16 |
| 2021-09-30 | $0.07B | $0.49B | 0.14 |
| 2021-06-30 | $0.07B | $0.45B | 0.15 |
| 2021-03-31 | $0.03B | $0.21B | 0.15 |
| 2020-12-31 | $0.03B | $0.21B | 0.14 |
| 2020-09-30 | $0.01B | $0.19B | 0.05 |
| 2020-06-30 | $0.01B | $0.11B | 0.08 |
| 2020-03-31 | $0.03B | $0.07B | 0.40 |
| 2019-12-31 | $0.05B | $0.04B | 1.14 |
| 2019-09-30 | $0.01B | $0.08B | 0.09 |
| 2019-06-30 | $0.01B | $0.05B | 0.12 |
| 2019-03-31 | $0.00B | $0.04B | 0.08 |
| 2018-12-31 | $0.03B | $0.02B | 2.11 |
| 2018-09-30 | $0.00B | $0.04B | 0.06 |
| 2018-06-30 | $0.00B | $0.02B | 0.11 |
| 2018-03-31 | $0.00B | $0.01B | 0.17 |
| 2017-12-31 | $0.00B | $0.01B | 0.20 |
| 2017-09-30 | $0.00B | $0.01B | 0.23 |
| 2017-06-30 | $0.00B | $0.01B | 0.24 |
| 2017-03-31 | $0.01B | $0.00B | 2.07 |
| 2016-12-31 | $0.01B | $0.00B | 1.50 |
| 2016-09-30 | $0.00B | $0.01B | 0.63 |
| 2016-06-30 | $0.00B | $0.01B | 0.40 |
| 2016-03-31 | $0.00B | $0.01B | 0.26 |
| 2015-12-31 | $0.00B | $0.01B | 0.26 |
| 2015-09-30 | $0.00B | $0.01B | 0.23 |
| 2015-06-30 | $0.00B | $0.01B | 0.17 |
| 2015-03-31 | $0.00B | $0.01B | 0.18 |
| 2014-12-31 | $0.00B | $0.01B | 0.15 |
| 2014-09-30 | $0.00B | $0.01B | 0.13 |
| 2014-06-30 | $0.00B | $0.01B | 0.11 |
| 2014-03-31 | $0.00B | $0.01B | 0.14 |
| 2013-12-31 | $0.02B | $-0.01B | -1.25 |
| 2013-09-30 | $0.02B | $-0.01B | -1.25 |
| 2013-06-30 | $0.02B | $-0.01B | -1.27 |
| 2013-03-31 | $0.02B | $-0.01B | -1.28 |
| 2012-12-31 | $0.02B | $-0.01B | -1.25 |
| 2012-09-30 | $0.02B | $-0.01B | -1.28 |
| 2012-06-30 | $0.02B | $-0.01B | -1.26 |
| 2012-03-31 | $0.01B | $-0.01B | -1.16 |
| 2011-12-31 | $0.01B | $-0.01B | -1.15 |
| 2011-09-30 | $0.01B | $-0.01B | -1.15 |
| 2011-06-30 | $0.01B | $-0.01B | -1.14 |
| 2011-03-31 | $0.01B | $-0.01B | -1.14 |
| 2010-12-31 | $0.01B | $-0.01B | -1.14 |
| 2010-09-30 | $0.01B | $-0.01B | -1.14 |
| 2010-06-30 | $0.01B | $-0.01B | -1.16 |
| 2010-03-31 | $0.01B | $-0.01B | -1.16 |
| 2009-12-31 | $0.01B | $-0.01B | -1.17 |
| 2009-09-30 | $0.01B | $-0.01B | -1.18 |
| 2009-06-30 | $0.01B | $-0.01B | -1.17 |
| 2009-03-31 | $0.01B | $-0.01B | -1.29 |
| 2008-12-31 | $0.01B | $-0.01B | -1.23 |
| 2008-09-30 | $0.01B | $0.00B | -1.30 |
| 2008-06-30 | $0.01B | $0.00B | -1.23 |
| 2008-03-31 | $0.00B | $0.00B | -1.28 |
| 2007-12-31 | $0.00B | $0.00B | -1.29 |
| 2007-09-30 | $0.00B | $0.00B | -1.84 |
| 2007-06-30 | $0.00B | $0.00B | -2.14 |
| 2007-03-31 | $0.00B | $0.00B | -3.45 |
| 2006-12-31 | $0.00B | $0.00B | 2.11 |
| 2006-09-30 | $0.00B | $0.00B | 3.15 |
| 2006-06-30 | $0.00B | $0.00B | 0.66 |
| 2006-03-31 | $0.00B | $0.00B | -2.95 |
| 2005-12-31 | $0.00B | $0.00B | 10.61 |
| 2005-09-30 | $0.00B | $0.00B | 2.55 |
| 2005-06-30 | $0.00B | $0.00B | 0.76 |
| 2005-03-31 | $0.00B | $0.00B | 0.45 |
| 2004-12-31 | $0.00B | $0.00B | 0.36 |
| 2004-09-30 | $0.00B | $0.00B | 0.32 |
| 2004-06-30 | $0.00B | $0.00B | 0.26 |
| 2004-03-31 | $0.00B | $0.00B | 0.17 |
| 2003-12-31 | $0.00B | $0.00B | 1.19 |
| 2003-09-30 | $0.00B | $0.00B | -1.21 |
| 2003-06-30 | $0.00B | $0.00B | -1.36 |
| 2003-03-31 | $0.00B | $0.00B | -1.44 |
| 2002-12-31 | $0.00B | $0.00B | -1.57 |
| 2002-09-30 | $0.00B | $0.00B | 0.54 |
| 2002-06-30 | $0.00B | $0.00B | 1.38 |
| 2002-03-31 | $0.00B | $0.00B | -23.72 |
| 2001-12-31 | $0.00B | $0.00B | 4.72 |
| 2001-09-30 | $0.00B | $0.00B | 44.53 |
| 2001-06-30 | $0.00B | $0.00B | 0.69 |
| 2001-03-31 | $0.00B | $0.00B | 0.24 |
| 2000-12-31 | $0.00B | $0.00B | 0.10 |
| 2000-09-30 | $0.00B | $0.01B | 0.10 |
| 2000-06-30 | $0.00B | $0.01B | 0.35 |
| 2000-03-31 | $0.00B | $0.00B | 2.27 |
| 1999-12-31 | $0.00B | $0.00B | 1.65 |
| 1999-09-30 | $0.00B | $0.00B | 0.89 |
| 1999-06-30 | $0.00B | $0.00B | 0.75 |
| 1999-03-31 | $0.00B | $0.00B | 0.65 |
| 1998-12-31 | $0.00B | $0.00B | 0.90 |
| 1998-09-30 | $0.00B | $0.00B | 0.87 |
| 1998-06-30 | $0.00B | $0.00B | 0.79 |
| 1998-03-31 | $0.00B | $0.00B | 0.72 |
| 1997-12-31 | $0.00B | $0.00B | 0.57 |
| 1997-09-30 | $0.00B | $0.00B | 0.42 |
| 1997-06-30 | $0.00B | $0.00B | 0.48 |
| 1997-03-31 | $0.00B | $0.00B | 0.50 |
| 1996-12-31 | $0.00B | $0.00B | 0.51 |
| 1996-09-30 | $0.00B | $0.00B | 0.52 |
| 1996-06-30 | $0.00B | $0.00B | 0.90 |
| 1996-03-31 | $0.00B | $0.01B | 0.55 |
| 1995-12-31 | $0.00B | $0.00B | 1.00 |
| 1995-09-30 | $0.00B | $0.00B | 1.05 |
| 1995-06-30 | $0.00B | $0.00B | 1.11 |
| 1995-03-31 | $0.01B | $0.00B | 1.03 |
| 1994-12-31 | $0.00B | $0.01B | 0.81 |
| 1994-09-30 | $0.00B | $0.01B | 0.82 |
| 1994-06-30 | $0.00B | $0.01B | 0.71 |
| 1994-03-31 | $0.00B | $0.00B | 1.08 |
| 1993-12-31 | $0.00B | $0.01B | 0.78 |
| 1993-09-30 | $0.00B | $0.01B | 0.58 |
| 1993-06-30 | $0.00B | $0.01B | 0.48 |
| 1993-03-31 | $0.00B | $0.01B | 0.24 |
| 1992-12-31 | $0.00B | $0.01B | 0.13 |
| 1992-09-30 | $0.00B | $0.01B | 0.13 |
| 1992-06-30 | $0.00B | $0.01B | 0.08 |
| 1992-03-31 | $0.00B | $0.00B | 0.14 |
| 1991-12-31 | $0.00B | $0.00B | 0.00 |
| 1991-09-30 | $0.00B | $0.01B | 0.00 |
| 1991-06-30 | $0.00B | $0.01B | 0.03 |
| 1991-03-31 | $0.00B | $0.00B | 0.08 |
| 1990-12-31 | $0.00B | $0.00B | 0.08 |
| 1990-09-30 | $0.00B | $0.00B | 0.11 |
| 1990-06-30 | $0.00B | $0.00B | 0.07 |
| 1990-03-31 | $0.00B | $0.00B | 0.02 |
| 1989-12-31 | $0.00B | $0.00B | 0.04 |
| 1989-06-30 | $0.00B | $0.00B | 4.32 |
| 1988-12-31 | $0.00B | $0.00B | 3.69 |
| 1988-09-30 | $0.00B | $0.00B | 0.04 |
| 1988-06-30 | $0.00B | $0.00B | -1.91 |
| 1988-03-31 | $0.00B | $0.00B | 3.69 |
| 1987-12-31 | $0.00B | $0.00B | -1.91 |
| 1987-03-31 | $0.00B | $0.00B | -1.91 |
| 1986-12-31 | $0.00B | $0.00B | -1.91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.953B | $0.096B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Stryker (SYK) | United States | $129.889B | 24.88 |
| Medtronic (MDT) | Ireland | $111.968B | 15.57 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Koninklijke Philips (PHG) | Netherlands | $27.260B | 16.18 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Insulet (PODD) | United States | $13.640B | 39.54 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Prestige Consumer Healthcare (PBH) | United States | $2.676B | 12.62 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.495B | 3.96 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.143B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |